Buy Gilead Sciences Shares

Gilead Sciences Logo

How COVID-19 has impacted Gilead Sciences and measures they’ve taken as a business to combat it. Read on below.

Gilead Sciences Shares

Our aim is to help you buy Gilead Sciences shares armed with as much research and information as possible.

Below we’ve aggregated up to date information on Gilead Sciences including a detailed coronavirus section, full company information and live share prices and trend graphs. We’ve also added a step by step guide showing you exactly how to buy Gilead Sciences shares.

About Gilead Sciences

Gilead Sciences is an innovative co-operation that finds, manufactures, and commercializes therapeutics to enhance the care of individuals who are suffering from life-threatening diseases. Gilead Sciences, Inc. focuses primarily on Liver disease, HIV, AIDS, severe eye, respiratory, and cardiovascular health conditions. 

The company was founded by Michael Riordan when he was 29 years old, in 1987. The company moved to California the following year, and that was after it raised its first VC fund of $2million. Ever since then, the California based biopharmaceutical company has steadily increased in strength with over 1000 employees.

Though not the owner of Gilead Sciences, Inc. The Vanguard Group, Inc. is the highest shareholder of Gilead Sciences with an 8.07% stake in the company.

How Coronavirus has impacted Gilead Sciences' share price

Gilead Sciences has been touted as a potential developer of an experimental drug to help fight (or even cure) coronavirus. This has naturally impacted their share price.

Below is a timeline on how the Coronavirus has affected the share price of Gilead and how they’re helping in fighting against this virus.

March 25th

Gilead Sciences backed off on a monopoly claim for their viral drug, which has been reported to show promising signs with patients suffering from the Coronavirus.

APRIL 5TH

The company announced that it would be donating about 1.5 million doses of remdesivir (its anti-coronavirus experimental drug, which could treat about 140,000 COVID-19 patients.

APRIL 8TH

VOA News reported that thousands of COVID-19 patients flood to join the studies of Gilead Sciences drug remdesivir that has shown promise in combating the two other types of coronaviruses.

April 16TH

The shares of the biopharmaceutical company surged in late trading after it was reported that some patients who were treated in Chicago are seeing quick recoveries in respiratory symptoms and fever.

April 23rd

CNBC reports that Gilead Sciences, Inc. that shares fell after a leaked draft document, which said that their produced anti-viral drug for COVID-19 did not improve the conditions of the patients.

How to buy Gilead Sciences shares

It’s a very simple and straightforward process to getting started and owning a share of Gilead Sciences. Our step by step guide below will show you just how easy.

1. Pick a share trading platform.
We’ve provided a selection below to help you choose (many come with an app that you can manage from your phone).

2. Open an account with your chosen trading platform.
As with any account you’l be required to identify yourself with some personal details to make sure you are who you say you are.

3. Add a payment method.
You’ll be securely transferring money to your share trading platform in order to buy the shares, so you’ll need to add a way to pay.

4. Search for the company you want to buy shares in.
Each share trading platform has a simple way to locate the company you’ve identified.

5. Buy the shares.
Make sure you check the share price of the company you’re investing in and how much you’re investing (and ensure you’re happy with both) before you click the ‘buy’ button.

And that’s it, you’re now a shareholder. Congratulations!

Always remember that the value of your investments can go down as well as up. There’s a chance you may end up with less than you begin with. Capital is at risk.

Compare Brokers

We’ve compared the top trading platforms side by side, so you don’t have to. Choose the platform that suits your needs best.

Award winning, advanced trading platform.

ASSETS

Stocks, Options, ETFs, Futures

STOCK TRADE FEE

$0

OPTION TRADE FEE

$0 + $1 per contract     OR

$2.50 per contract

ANNUAL FEE

0%

GO TO BROKER

Ally Invest

Very low fees plus a cash bonus offering.

ASSETS

Stocks, Options, Bonds, ETFs, Forex, Mutual funds

STOCK TRADE FEE

$0

OPTION TRADE FEE

$0 + $0.50 per contract 

ANNUAL FEE

0%

GO TO BROKER

Robinhood

No commission, forex fees or account minimums.

ASSETS

Stocks, Options, ETFs, Cryptocurrencies

STOCK TRADE FEE

$0

OPTION TRADE FEE

$0

ANNUAL FEE

0%

GO TO BROKER

Affiliate Disclaimer: Confideal may make a small amount of money through affiliate marketing when you sign up to any of the brokers listed on our website.

Confideal.io is an independent marketing website which only acts as an introducer to companies that offer share trading capabilities. Confideal.io is not authorised to give any advice and we are not liable for any financial advice provided by, or obtained through a third party. The information published on the Confideal.io website is for information purposes only. Confideal does not offer financial advice.

Copyright Confideal 2020. All rights reserved.